drug

itepekimab

1 story · latest Aug 31, 2026

Status: Investigational
Codes: REGN3500, SAR440340
Trials: 4 registered trials in coverage

Relationships

Developed by Sanofi

Timeline

Sanofi's itepekimab COPD mechanism study AERIFY-3 posts results after 2025 completion

Aug 31Trial updateitepekimab Regeneron Pharmaceuticals

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.